Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Sale | 2024-02-20 4:06 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,615 | $15.62 | $40,840 | 177,839 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,435 | $14.47 | $35,234 | 94,079 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,792 | $15.37 | $42,905 | 96,514 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:11 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,360 | $12.02 | $28,362 | 90,628 (Direct) | View |
| 2023-10-02 Sale | 2023-10-04 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,942 | $12.68 | $37,305 | 84,744 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 1,655 | $14.4 | $23,835 | 87,686 (Direct) | View |
| 2023-02-16 Sale | 2023-02-17 4:07 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 971 | $15.1 | $14,661 | 154,045 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,403 | $21.24 | $51,043 | 72,628 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,587 | $18.73 | $48,455 | 74,297 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:37 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 1,768 | $10.75 | $19,006 | 76,884 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 984 | $9.05 | $8,905 | 76,790 (Direct) | View |
| 2021-10-04 Sale | 2021-10-06 4:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,659 | $33.17 | $88,199 | 46,029 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 132 | $48.87 | $6,451 | 98,286 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Option Award | 2024-02-20 4:06 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 86,375 | $0 | 177,839 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 8,244 | $0 | 96,514 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:11 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 8,244 | $0 | 90,628 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:45 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:07 pm | N/A 2033-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 82,388 | $0 | 154,045 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:02 pm | N/A 2032-06-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 102,500 | $0 | 159,774 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:05 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 93,365 | $0 | 139,539 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 5:38 pm | N/A 2031-06-25 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:00 pm | N/A 2031-02-15 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 61,000 | $0 | 98,286 (Direct) | View |
| 2020-12-09 Exercise | 2020-12-11 4:10 pm | N/A 2029-10-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 207 | $0 | 184,514 (Direct) | View |
| 2020-12-09 Exercise | 2020-12-11 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 207 | $34.43 | 184,514 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:31 pm | N/A 2029-10-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,697 | $0 | 184,514 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:31 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,697 | $34.43 | 184,514 (Direct) | View |
| 2020-10-02 Tax Withholding | 2020-10-06 4:00 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,632 | $51.15 | 34,128 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 4:46 pm | N/A 2030-06-23 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A 2030-02-17 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 12,280 | $0 | 47,280 (Direct) | View |
| 2020-01-25 Option Award | 2020-01-28 4:22 pm | N/A 2030-01-25 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-17 4:35 pm | N/A 2029-10-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 185,000 | $0 | 185,000 (Direct) | View |
| 2019-07-31 Disposition | 2019-08-02 6:39 pm | 2019-04-30 2028-04-29 | NEWLINK GENETICS CORP | NLNK | Sherman Matthew L Director | 91,224 | $0 | 45,613 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-02 6:39 pm | N/A 2026-07-31 | NEWLINK GENETICS CORP | NLNK | Sherman Matthew L Director | 45,613 | $0 | 45,613 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 4:13 pm | N/A 2029-05-16 | Pulmatrix Inc. | PULM | Sherman Matthew L Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-05-10 Option Award | 2019-05-14 5:33 pm | N/A 2029-05-09 | NEWLINK GENETICS CORP | NLNK | Sherman Matthew L Director | 25,000 | $0 | 25,000 (Direct) | View |